# ClinicalTrials.gov record NCT01431391

> PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct01431391-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-05-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01431391-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01431391-leuprolide-v1.json
- Content SHA-256: `7acb245cef482efffd53e8d31fb2f6a1d99f743c1f1682373e4b488093bd927b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01431391 ([`ctg-observation-nct01431391-2017-05-30-e8997f72c533`](#source-ctg-observation-nct01431391-2017-05-30-e8997f72c533))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01431391-2017-05-30-e8997f72c533`](#source-ctg-observation-nct01431391-2017-05-30-e8997f72c533))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01431391-2017-05-30-e8997f72c533`](#source-ctg-observation-nct01431391-2017-05-30-e8997f72c533))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01431391-2017-05-30-e8997f72c533`](#source-ctg-observation-nct01431391-2017-05-30-e8997f72c533))

## Sources

<a id="source-ctg-observation-nct01431391-2017-05-30-e8997f72c533"></a>
- **ClinicalTrials.gov record NCT01431391 · retained source version 2017-05-30:e8997f72c533e9a58e6df211dba467baf8ed1d679f7603c04b9d2e307a506df1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01431391) (`ctg-observation-nct01431391-2017-05-30-e8997f72c533`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01431391." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01431391-leuprolide-v1.json SHA-256: 7acb245cef482efffd53e8d31fb2f6a1d99f743c1f1682373e4b488093bd927b.